Diabetes drug class not clearly linked to added harm in adults 75-plus
A Canadian cohort compared 4,997 older adults starting one diabetes drug class with 1,289 starting another, but some harm estimates remained imprecise.A Canadian cohort compared 4,997 older adults starting one diabetes drug class with 1,289 starting another, but some harm estimates remained imprecise.